greeksoup/ stock research

Colgate-Palmolive (CL) FY2023 results: revenue $19.5 billion, up 8.3% on the year

Colgate-Palmolive Co. (CL) reported revenue of $19.5 billion for fiscal 2023, the year ended 31 December 2023, up 8.3% on the year before. Net income was $2.3 billion, up 28.9%, and diluted earnings per share $2.77. The figures are the company's own, from the 10-K it filed with the SEC on 15 February 2024.

Revenue
$19.5 billion
+8.3% on the year
FY2016FY2023
Operating margin
20.5%
16.1% a year earlier
FY2016FY2023
Net income
$2.3 billion
+28.9% on the year
FY2016FY2023
Diluted EPS
$2.77
+30.0% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue19,45717,96717,421+8.3%
Cost of revenue8,1317,7197,046+5.3%
Gross profit11,32610,24810,375+10.5%
Gross margin58.2%57.0%59.6%
Research and development343320307+7.2%
Selling, general and administrative7,1516,5656,407+8.9%
Operating income3,9842,8933,332+37.7%
Operating margin20.5%16.1%19.1%
Interest expense287167120+71.9%
Pre-tax income3,3922,6603,087+27.5%
Income tax937693749+35.2%
Effective tax rate27.6%26.1%24.3%
Net income2,3001,7852,166+28.9%
Net margin11.8%9.9%12.4%
Diluted EPS$2.77$2.13$2.55+30.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow3,7452,5563,325+46.5%
Capital expenditure705696567+1.3%
Free cash flow3,0401,8602,758+63.4%
Free cash flow margin15.6%10.4%15.8%
Cash from investing-742-1,601-592
Cash from financing-2,793-952-2,774
Depreciation and amortisation567545556+4.0%
Share-based compensation122125135-2.4%
Buybacks1,1281,3081,320-13.8%
Dividends paid1,7491,6911,679+3.4%
Dividend per share$1.91$1.86$1.79+2.7%
Diluted shares, weighted829m839m848m-1.1%
Shares outstanding at period end821m830m840m-1.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity609401609+51.9%
Non-controlling interest348405362-14.1%
Debt8,5498,7557,245-2.4%
Operating lease liabilities420397451+5.8%
Other liabilities6,4675,7736,373+12.0%
Total liabilities and equity16,39315,73115,040+4.2%
Fixed assets4,5824,3073,730+6.4%
Goodwill3,4103,3523,284+1.7%
Intangible assets1,8871,9202,462-1.7%
Investments179n/an/a
Cash and equivalents966775832+24.6%
Receivables1,5861,5041,297+5.5%
Inventory1,9342,0741,692-6.8%
Other assets1,8491,7991,743+2.8%
Total assets16,39315,73115,040+4.2%

10-K for the year ended 31 December 2023, filed 15 February 2024: the filing.